SAVA, M.; SOMMER, G.; DAIKELER, T.; WOISCHNIG, A.-K.; MARTINEZ, A. E.; LEUZINGER, K.; HIRSCH, H. H.; ERLANGER, T. E.; WIENCIERZ, A.; BASSETTI, S.; TAMM, M.; TSCHUDIN-SUTTER, S.; STOECKLE, M.; PARGGER, H.; SIEGEMUND, M.; BOSS, R.; ZIMMER, G.; VU, D.-L.; KAISER, L.; DELL-KUSTER, S.; WEISSER, M.; BATTEGAY, M.; HOSTETTLER, K. E.; KHANNA, N. Ninety-day outcome of patients with severe COVID-19 treated with tocilizumab – a single centre cohort study. Swiss Medical Weekly, [S. l.], v. 151, n. 3132, p. w20550, 2021. DOI: 10.4414/smw.2021.20550. Disponível em: https://smw.ch/index.php/smw/article/view/3045. Acesso em: 30 apr. 2024.